PTTG1IP expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 8.49953440962281E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.19690002143136E-09 |
Normal-vs-Stage2 |
6.165000E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.724300E-03 |
Stage1-vs-Stage2 |
1.115040E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.687900E-02 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.123600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.3051998611694E-10 |
Normal-vs-AfricanAmerican |
1.600840E-01 |
Normal-vs-Asian |
4.616400E-02 |
Caucasian-vs-AfricanAmerican |
6.950800E-01 |
Caucasian-vs-Asian |
6.371400E-01 |
AfricanAmerican-vs-Asian |
3.920600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.56200000003926E-06 |
Normal-vs-Female |
3.13359999948304E-07 |
Male-vs-Female |
1.312360E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.644200E-04 |
Normal-vs-Extreme_Weight |
2.367900E-04 |
Normal-vs-Obese |
2.198100E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
8.972600E-01 |
Normal_Weight-vs-Obese |
9.644400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.438600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.951400E-01 |
Normal-vs-Age(41-60Yrs) |
5.91770000002434E-07 |
Normal-vs-Age(61-80Yrs) |
4.95730000049655E-07 |
Normal-vs-Age(81-100Yrs) |
1.795900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.400800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.171800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.571000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.860570E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.478290E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.009800E-02 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.523600E-02 |
Normal-vs-Grade 3 |
9.506300E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.471200E-01 |
Grade 2-vs-Grade 4 |
9.523600E-02 |
Grade 3-vs-Grade 4 |
9.506300E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.3344999549858E-09 |
Normal-vs-N1 |
1.406280E-02 |
N0-vs-N1 |
1.130180E-01 |
|
|